Abstract
Hand dermatitis (eczema) is a common, but often difficult to diagnose, dermatological condition. Management of hand dermatitis should involve the use of preventive measures and appropriate treatment options based on the severity of the condition, with stepwise escalation of treatment when necessary. Therapeutic options for less severe disease include basic topical therapy, topical corticosteroids, calcineurin inhibitors, phototherapy and retinoids, with systemic corticosteroids and other immunosuppressive agents being reserved for the treatment of more severe disease.
Similar content being viewed by others
References
Diepgen TL, Agner T, Aberer W, et al. Management of chronic hand eczema. Contact Dermatitis. 2007;57(4):203–10.
Antonov D, Schliemann S, Elsner P. Hand dermatitis: a review of clinical features, prevention and treatment. Am J Clin Dermatol. 2015;16(4):257–70.
Bissonnette R, Diepgen TL, Elsner P, et al. Redefining treatment options in chronic hand eczema (CHE). J Eur Acad Dermatol Venereol. 2010;24(Suppl 3):1–20.
Diepgen TL, Andersen KE, Chosidow O, et al. Guidelines for diagnosis, prevention and treatment of hand eczema. J Dtsch Dermatol Ges. 2015;13(1):e1–22.
Loden M. The clinical benefit of moisturizers. J Eur Acad Dermatol Venereol. 2005;19(6):672–88.
Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17(12):1063–72.
Luger T, Loske KD, Elsner P, et al. Topical skin therapy with glucocorticoids: therapeutic index [in German]. J Dtsch Dermatol Ges. 2004;2(7):629–34.
Veien NK, Olholm Larsen P, Thestrup-Pedersen K, et al. Long-term, intermittent treatment of chronic hand eczema with mometasone furoate. Br J Dermatol. 1999;140(5):882–6.
Hachem JP, De Paepe K, Vanpee E, et al. Combination therapy improves the recovery of the skin barrier function: an experimental model using a contact allergy patch test combined with TEWL measurements. Dermatology. 2001;202(4):314–9.
Luger T, Paul C. Potential new indications of topical calcineurin inhibitors. Dermatology. 2007;215(Suppl 1):45–54.
Belsito DV, Fowler JF Jr, Marks JG Jr, et al. Pimecrolimus cream 1 %: a potential new treatment for chronic hand dermatitis. Cutis. 2004;73(1):31–8.
Schliemann S, Kelterer D, Bauer A, et al. Tacrolimus ointment in the treatment of occupationally induced chronic hand dermatitis. Contact Dermatitis. 2008;58(5):299–306.
Margolis DJ, Abuabara K, Hoffstad OJ, et al. Association between malignancy and topical use of pimecrolimus. JAMA Dermatol. 2015;151(6):594–9.
Wollenberg A, Frank R, Kroth J, et al. Proactive therapy of atopic eczema: an evidence-based concept with a behavioral background. J Dtsch Dermatol Ges. 2009;7(2):117–21.
Ruzicka T, Lynde CW, Jemec GB, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol. 2008;158(4):808–17.
Hanifin JM, Stevens V, Sheth P, et al. Novel treatment of chronic severe hand dermatitis with bexarotene gel. Br J Dermatol. 2004;150(3):545–53.
Thestrup-Pedersen K, Andersen KE, Menne T, et al. Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin: a single-blind placebo-controlled study. Acta Derm Venereol. 2001;81(5):353–5.
Granlund H, Erkko P, Eriksson E, et al. Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol. 1996;76(5):371–6.
Schmitt J, Schmitt N, Meurer M. Cyclosporin in the treatment of patients with atopic eczema: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2007;21(5):606–19.
Verma KK, Bansal A, Sethuraman G. Parthenium dermatitis treated with azathioprine weekly pulse doses. Indian J Dermatol Venereol Leprol. 2006;72(1):24–7.
Egan CA, Rallis TM, Meadows KP, et al. Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J Am Acad Dermatol. 1999;40(4):612–4.
Shaffrali FC, Colver GB, Messenger AG, et al. Experience with low-dose methotrexate for the treatment of eczema in the elderly. J Am Acad Dermatol. 2003;48(3):417–9.
Pickenacker A, Luger TA, Schwarz T. Dyshidrotic eczema treated with mycophenolate mofetil. Arch Dermatol. 1998;134(3):378–9.
Brasch J, Becker D, Aberer W, et al. Contact dermatitis. J Dtsch Dermatol Ges. 2007;5(10):943–51.
Schempp CM, Muller H, Czech W, et al. Treatment of chronic palmoplantar eczema with local bath-PUVA therapy. J Am Acad Dermatol. 1997;36(5 Pt 1):733–7.
Polderman MC, Govaert JC, le Cessie S, et al. A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema. Clin Exp Dermatol. 2003;28(6):584–7.
Petering H, Breuer C, Herbst R, et al. Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. J Am Acad Dermatol. 2004;50(1):68–72.
Stege H. Ultraviolet therapy in patients with chronic hand eczema [in German]. Hautarzt. 2008;59(9):696–702.
Fairris GM, Jones DH, Mack DP, et al. Superficial X-ray therapy in the treatment of constitutional eczema of the feet. Br J Dermatol. 1984;111(4):500–2.
Lofgren SM, Warshaw EM. Dyshidrosis: epidemiology, clinical characteristics, and therapy. Dermatitis. 2006;17(4):165–81.
Handa S, Sahoo B, Sharma VK. Oral hyposensitization in patients with contact dermatitis from Parthenium hysterophorus. Contact Dermatitis. 2001;44(5):279–82.
Author information
Authors and Affiliations
Consortia
Ethics declarations
This article was adapted from the American Journal of Clinical Dermatology 2015;16(4):257–70 [2] by salaried/contracted employees of Adis/Springer and was not supported by any external funding.
Rights and permissions
About this article
Cite this article
Adis Medical Writers. Manage hand dermatitis with preventative measures and a stepwise approach to escalating therapy. Drugs Ther Perspect 31, 385–389 (2015). https://doi.org/10.1007/s40267-015-0247-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40267-015-0247-4